tertiary hospitallenvatinibsorafenibhepatocellular carcinomaAtezolizumab-Bevacizumab
… patients treated with ATZ-BVZ from May 2021 to April 2025 in a tertiary hospital.The variables studied were demographic data, ECOG, number of cy…
11,350articles mentioning institutions
22,378institution mentions
9,137distinct institutions extracted
0%of mentions human-reviewed
All extracted institutions
Showing 1,981–2,040 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
A&E1ACCORD1ADSTILADRIN1AGENAS1AGU1AIC Kijabe Hospital1AKUH1ALERT Comprehensive Specialised Hospital1ALSWH1AMBOSS1ANRS-PREVENIR1ANZCRT1APPAC IV1ATC group C071AZUR-21Aalen University1Agogo Presbyterian Hospital1Albany Medical College1Aliment Pharmacol Ther1Allegheny Health1AllofUS1Alomone Labs1American Dental Association1American Journal of Gastroenterology1American Society of Transplantation1Amiens-Picardie University Hospital1Aneuvas Technologies, Inc1Archambault et al1Arm 31Asociación Latinoamericana para el Estudio del Hígado1AstraZeneca1Atrium Health Carolinas Medical Center1BD Biosciences1BE MOBILE 11BIDMC1BIOME study1BMHI1BSGE1BSU1BabyGel trial1Baxter et al1Beijing1Beijing Friendship Hospital1Beijing Huilongguan Hospital1Benchmark-SLE1BioMedware1BioMere1BornFyne1Boston University Medical Center1Brain Aneurysm Foundation1Brain-Heart team1Brightline1Bristol Myers Squibb1British Menopause Society1BronchUK Registry1Brown University Health Institutional Review Board1C-STACS1CAMP1CANN20211CASEM1
Articles mentioning institutions
11,350 articles · page 571 of 946ORPHANETbosentandaratumumabazacitidineibrutinibnintedanibrare diseasesRDnational health authorities
…cy software (Farmatools), using OD classifications validated by ORPHANET (last update: April 2024). Drug prices were based on those publ…
tertiary children’s hospitalFenfluramineLennox–Gastaut syndromeDravet syndromecannabidiolLGSDS
…eated with fenfluramine between January 2021 and July 2025 at a tertiary children’s hospital. Demographic, clinical, and treatment variables were collected.…
Salesi HospitalLennox–Gastaut syndromeDravet SyndromeTuberous Sclerosis ComplexEpilepsyclobazamAIFAepilepsiesCannabidiolTSC+2 more
…ted with add-on CBD at the Regional Paediatric Epilepsy Centre, Salesi Hospital (Ancona, Italy) between September 2019 and December 2023 were a…
tertiary care hospitalsisavuconazolevoriconazoleposaconazolesevere fungal infectionsTriazole antifungalsazole antifungals
…bility of azole antifungals in paediatric patients monitored in tertiary care hospitals, analysing the impact of therapeutic drug monitoring.Material a…
NAPOLI-1 trialgemcitabine-nabpaclitaxelMetastatic pancreatic cancerliposomal irinotecanNALIRIfluorouracilmPCfolinic acid
…vance The effectiveness of NALIRI was comparable to that of the NAPOLI-1 trial. NALIRI showed a high incidence of adverse effects, which in ma…
tertiary care hospitalhypercholesterolaemiaevolocumabalirocumabPCSK9iezetimibebempedoic acid
…ugs in the hospital guidelines (August 2016–February 2025) at a tertiary care hospital. Data collected: age, sex, lipid-lowering treatment, adherence,…
tertiary hospitalOritavancinOAIEnterococcus faecalismultidrug-resistant gram-positive cocci
…(date of inclusion in the hospital formulary) to July 2025 in a tertiary hospital. Variables evaluated: age, sex, type of infection, isolated mic…
local ethics committeeVancomycinceftarolinelinezolidclindamycindaptomycinGram-positive bacterial infectionspneumoniabacteraemiacentral nervous system infections+2 more
… clinically unstable patients. The protocol was approved by the local ethics committee.Results A total of 836 vancomycin treatments were administered …
MedinteractapixabanrivaroxabanDabigatranedoxabanthromboembolic eventsDOACs
…abigatran) listed in four drug interaction databases (Lexicomp, Medinteract, Micromedex, Drugs.com). Interaction severity was standardised …
tertiary care hospitalRisankizumabulcerative colitispsoriasisCrohn’s diseasepsoriatic arthritisPsAPsOUC
…atients with PsO, PsA, CD and UC treated with risankizumab in a tertiary care hospital from March 2021 to July 2025.The variables collected were: sex,…
tertiary care hospitalCladribineRRMSrelapsing–remitting multiple sclerosisDMT
… control.Aim and Objectives Evaluate the use of cladribine in a tertiary care hospital.Material and Methods A retrospective analysis was conducted wit…